| Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients S Delalande, J de Seze, AL Fauchais, E Hachulla, T Stojkovic, D Ferriby, ... Medicine 83 (5), 280-291, 2004 | 842 | 2004 |
| Long-term observational study of sporadic inclusion body myositis O Benveniste, M Guiguet, J Freebody, O Dubourg, W Squier, ... Brain 134 (11), 3176-3184, 2011 | 321 | 2011 |
| Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin Y Allenbach, L Drouot, A Rigolet, JL Charuel, F Jouen, NB Romero, ... Medicine 93 (3), 150-157, 2014 | 313 | 2014 |
| A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis P Zisimopoulou, P Evangelakou, J Tzartos, K Lazaridis, V Zouvelou, ... Journal of autoimmunity 52, 139-145, 2014 | 303 | 2014 |
| Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases J de Seze, T Stojkovic, G Breteau, C Lucas, U Michon-Pasturel, JY Gauvrit, ... Brain 124 (8), 1509-1521, 2001 | 279 | 2001 |
| Multiple phenotypes in phosphoglucomutase 1 deficiency LC Tegtmeyer, S Rust, M van Scherpenzeel, BG Ng, ME Losfeld, S Timal, ... New England Journal of Medicine 370 (6), 533-542, 2014 | 275 | 2014 |
| High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody Y Allenbach, J Keraen, A Bouvier, V Jooste, N Champtiaux, B Hervier, ... Brain 139 (8), 2131-2135, 2016 | 257 | 2016 |
| Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile J De Seze, T Stojkovic, D Ferriby, JY Gauvrit, C Montagne, ... Journal of the neurological sciences 197 (1-2), 57-61, 2002 | 254 | 2002 |
| Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy L Gueneau, AT Bertrand, JP Jais, MA Salih, T Stojkovic, M Wehnert, ... The American Journal of Human Genetics 85 (3), 338-353, 2009 | 245 | 2009 |
| Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial P Gajdos, C Tranchant, B Clair, F Bolgert, B Eymard, T Stojkovic, ... Archives of neurology 62 (11), 1689-1693, 2005 | 230 | 2005 |
| A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy K Viala, T Maisonobe, T Stojkovic, R Koutlidis, X Ayrignac, L Musset, ... Journal of the peripheral nervous system 15 (1), 50-56, 2010 | 196 | 2010 |
| Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study TA Willis, KG Hollingsworth, A Coombs, ML Sveen, S Andersen, ... PloS one 8 (8), e70993, 2013 | 187 | 2013 |
| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 184 | 2019 |
| Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion A Cortese, S Tozza, WY Yau, S Rossi, SJ Beecroft, Z Jaunmuktane, ... Brain 143 (2), 480-490, 2020 | 182 | 2020 |
| Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis J De Seze, C Lebrun, T Stojkovic, D Ferriby, M Chatel, P Vermersch Multiple Sclerosis Journal 9 (5), 521-525, 2003 | 179 | 2003 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 176 | 2020 |
| Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease K Wahbi, C Meune, R Porcher, HM Bécane, A Lazarus, P Laforêt, ... Jama 307 (12), 1292-1301, 2012 | 172 | 2012 |
| Follow-up of patients with history of cervical artery dissection D Leys, TH Moulin, T Stojkovic, S Begey, D Chavot Cerebrovascular Diseases 5 (1), 43-49, 1995 | 169 | 1995 |
| Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies K Wahbi, R Ben Yaou, E Gandjbakhch, F Anselme, T Gossios, ... Circulation 140 (4), 293-302, 2019 | 160 | 2019 |
| Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial J Micallef, S Attarian, O Dubourg, PM Gonnaud, JY Hogrel, T Stojkovic, ... The Lancet Neurology 8 (12), 1103-1110, 2009 | 156 | 2009 |
